Brian A. Johns - Concepedia

Author

Brian A. Johns

Research Triangle Park Foundation ORCID

Also Known As

B Johns, B. A. JOHNS, Brian A Johns, Brian A. Johns, Brian Johns, Johns, Brian A.

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)Shionogi (Japan)Futaba (Japan)Wayne State University

About

Brian A. Johns is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	36	2.5K
2	Natural Sciences	16	20	1.3K
3	Engineering	3	3	330
4	Social Sciences	2	2	239
5	Anesthesia	1	1	221

Brian A. Johns

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
<i>In Vitro</i>Antiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor Masanori Kobayashi, Tomokazu Yoshinaga, Takahiro Seki, Antimicrobial Agents and Chemotherapy NeurovirologyDrug DiscoveryMedicineImmunologyHuman Retrovirus	2010	371
Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression Paulo Shiroma, Brian A. Johns, Michael A. Kuskowski, Journal of Affective Disorders PsychiatryAddictionTreatment Resistant DepressionMedicinePsychotropic Medication	2013	221
Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes Kendra E. Hightower, Ruolan Wang, Felix Deanda, Antimicrobial Agents and Chemotherapy ImmunologyMolecular BiologySlower DissociationAntiviral DrugDrug Resistance	2011	221
Total Synthesis of (+)-Discodermolide James A. Marshall, Brian A. Johns The Journal of Organic Chemistry Cross-coupling ReactionEngineeringResultant Epoxy AlcoholsNatural SciencesDiversity-oriented Synthesis	1998	192
Carbamoyl Pyridone HIV-1 Integrase Inhibitors 3. A Diastereomeric Approach to Chiral Nonracemic Tricyclic Ring Systems and the Discovery of Dolutegravir (S/GSK1349572) and (S/GSK1265744) Brian A. Johns, Takashi Kawasuji, Jason G. Weatherhead, Journal of Medicinal Chemistry Medicinal ChemistryBioorganic ChemistryBiochemistryMedicineIntegrase Inhibitors	2013	181
Synthesis and Biological Evaluation of Aza-<i>C</i>-disaccharides: (1→6), (1→4), and (1→1) Linked Sugar Mimics Brian A. Johns, Yutian Pan, Alan D. Elbein, Journal of the American Chemical Society Medicinal ChemistryBiosynthesisBioorganic ChemistryEngineeringBiochemistry	1997	127
Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression Paulo Shiroma, C. Sophia Albott, Brian A. Johns, The International Journal of Neuropsychopharmacology	2014	121
Imidazo[1,2-a]pyridines with potent activity against herpesviruses Kristjan S. Gudmundsson, Brian A. Johns Bioorganic & Medicinal Chemistry Letters MedicineVirologyPotent ActivityAntiviral DrugPharmacology	2007	114
The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore Brian A. Johns, Jason G. Weatherhead, Scott H. Allen, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineAntiviral Drug DevelopmentAntiviral TherapyPharmacotherapy	2009	113
Emotion recognition processing as early predictor of response to 8‐week citalopram treatment in late‐life depression Paulo Shiroma, Paul Thuras, Brian A. Johns, International Journal of Geriatric Psychiatry	2014	108

Page 1